Login/Register

Anti-Globo H mAb for Cancer Therapy

Taiwan
Partnership wanted
Introduction
1. Anti-Globo H monoclonal antibody can maintain the high selectivity and activity of antibody drugs while treating cancer and increasing patients' lifespan and quality of life.

2. The candidate drug has the characteristics of a new target, patentability, high activity, and so on, and it is a first-in-class new drug with strong international competitiveness and development potential.
Features / strengths
- Globo H+ Cancer Treatment
- Higher number of breast cancer patients (61%)
- Demonstrated its anticancer efficacy in an animal model of breast cancer by ADCC and CDC.
- Low safety concerns for Anti-Globo H mAb based on GLP TCR results.
Specification in detail
Anti-Globo H mAb for Cancer Therapy
Anti-Globo H mAb for Cancer Therapy

Information
Introduction
1. Anti-Globo H monoclonal antibody can maintain the high selectivity and activity of antibody drugs while treating cancer and increasing patients' lifespan and quality of life.

2. The candidate drug has the characteristics of a new target, patentability, high activity, and so on, and it is a first-in-class new drug with strong international competitiveness and development potential.
Features / strengths
- Globo H+ Cancer Treatment
- Higher number of breast cancer patients (61%)
- Demonstrated its anticancer efficacy in an animal model of breast cancer by ADCC and CDC.
- Low safety concerns for Anti-Globo H mAb based on GLP TCR results.
Specification in detail
Anti-Globo H mAb for Cancer Therapy
Anti-Globo H mAb for Cancer Therapy

Anti-Globo H mAb for Cancer Therapy

Taiwan
DEVELOPMENT CENTER FOR BIOTECHNOLOGY Other products
Recommended